Innoviva, Inc.Innoviva, Inc.Innoviva, Inc.

Innoviva, Inc.

No trades
See on Supercharts
Market capitalization
‪925.02 M‬USD
‪−69.05 M‬USD
‪4.53 M‬USD
‪62.42 M‬
Beta (1Y)
0.49

About Innoviva, Inc.

CEO
Pavel Raifeld
Headquarters
Burlingame
Website
Founded
1996
ISIN
US45781M1018
FIGI
BBG000CG9XT7
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of INVA is 14.40 USD — it has decreased by 1.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Innoviva, Inc. stocks are traded under the ticker INVA.
Innoviva, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Innoviva, Inc. has a max estimate of 15.00 USD and a min estimate of 15.00 USD.
INVA earnings for the last quarter are 0.98 USD whereas the estimation was 0.27 USD which accounts for 262.96% surprise. Estimated earnings for the next quarter are 0.23 USD. See more details about Innoviva, Inc. earnings.
Innoviva, Inc. revenue for the last quarter amounts to ‪67.26 M‬ USD despite the estimated figure of ‪75.66 M‬ USD. In the next quarter revenue is expected to reach ‪75.52 M‬ USD.
Yes, you can track Innoviva, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, INVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innoviva, Inc. stock right from TradingView charts — choose your broker and connect to your account.
INVA reached its all-time high on Jul 12, 2013 with the price of 34.61 USD, and its all-time low was 3.48 USD and was reached on Nov 21, 2008.
See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Innoviva, Inc. EBITDA is ‪149.59 M‬ USD, and current EBITDA margin is −881.39%. See more stats in Innoviva, Inc. financial statements.